Ingrid Encinas
Psychiatric/Mental Health · Kissimmee, FLNPI 1447766480
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 251 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 19.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $2,986 and has fallen 61.3% since, to $1,154 in 2025. Among psychiatric/mental health clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 251 payments — averaging $28.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Alkermes, Inc.$1K
- Otsuka America Pharmaceutical, Inc.$750
- Teva Pharmaceuticals USA, Inc.$682
- Johnson & Johnson$606
- Axsome Therapeutics, Inc.$480
- plus $2K from 17 others
What the payments were for
- Food & beverage$7,129100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 67 | $1,417 |
| Alkermes, Inc. | 36 | $1,205 |
| Otsuka America Pharmaceutical, Inc. | 25 | $750 |
| Teva Pharmaceuticals USA, Inc. | 14 | $682 |
| Johnson & Johnson | 15 | $606 |
| Axsome Therapeutics, Inc. | 11 | $480 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 15 | $463 |
| Neurocrine Biosciences, Inc. | 8 | $265 |
| Sunovion Pharmaceuticals Inc. | 13 | $196 |
| Lundbeck LLC | 7 | $175 |
| Ironshore Pharmaceuticals Inc. | 6 | $121 |
| Livanova USA, Inc. | 1 | $120 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $118 |
| Vanda Pharmaceuticals Inc. | 5 | $107 |
| Corium, LLC | 4 | $87 |
| Supernus Pharmaceuticals, Inc. | 4 | $76 |
| E.r. Squibb & Sons, L.L.C. | 3 | $58 |
| Indivior Inc. | 3 | $53 |
| Noven Therapeutics, LLC | 2 | $45 |
| Idorsia Pharmaceuticals US Inc | 2 | $37 |
| Janssen Scientific Affairs, LLC | 1 | $34 |
| Acadia Pharmaceuticals Inc | 1 | $26 |
| Alfasigma USA, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ARISTADA$1,000
- LYBALVI$860
- AUSTEDO$369
- VRAYLAR$343
- INVEGA SUSTENNA$273
- ARISTADA INITIO$250
- CAPLYTA$249
- Auvelity$247
- INVEGA TRINZA$149
- REXULTI$125
- ABILIFY MAINTENA$125
- INGREZZA$123
- Austedo XR$120
- VNS Therapy Symmetry Model 8103 Generator$120
- SPRAVATO$100
How this compares
$7,136 in reported general payments places this provider in the 90th percentile of 3,096 psychiatric/mental health providers in Florida.
Other psychiatric/mental health in Kissimmee
- Roger RiveraKissimmee$1.6M
- Trinese HardyKissimmee$30K
- Bethanie Simmons BecilJacksonville$782K
- Hannah PhillipsMaitland$455K
- Scott DurrancePensacola$224K
- Eudaldo AponteHialeah$214K
- Heather WarrenTallahassee$172K
- Angela DavenportAlachua$83K
- Natalie MoodyWinter Haven$75K
- Kelli BridgmanNew Smyrna Beach$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.